Login / Signup

A nutraceutical strategy for downregulating TGFβ signalling: prospects for prevention of fibrotic disorders, including post-COVID-19 pulmonary fibrosis.

James J Di NicolantonioMark F McCartyJorge Barroso-ArandaSimon AssangaLidianys Maria Lewis LujanJames H O'Keefe
Published in: Open heart (2021)
Keyphrases
  • pulmonary fibrosis
  • coronavirus disease
  • sars cov
  • transforming growth factor
  • systemic sclerosis
  • current status
  • idiopathic pulmonary fibrosis
  • epithelial mesenchymal transition